Apoptosis of CD4+ T and natural killer cells in Alzheimer's disease

Pharmacopsychiatry

Volumn 39, Issue 6, 2006, Pages 220-228

  Schindowski, Katharina ^a,b   Peters, J ^a   Gorriz, C ^a,e   Schramm, U ^a   Weinandi, T ^a   Leutner, S ^a   Maurer, K ^a   Frolich L ^a,d   Muller W E ^a   Eckert, A ^a,c  

^a GOETHE UNIVERSITY   (Germany)

^b INSERM   (France)

^c University Psychiatric Hospitals   (Switzerland)

^d Central Institute for Mental Health   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; PROTEIN BCL 2;

AGED; AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CELL DEATH; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIGENS, SURFACE; APOLIPOPROTEINS E; APOPTOSIS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COGNITION; FEMALE; GENES, BCL-2; GENOTYPE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, TRANSGENIC; MONOCYTES; NEUROPSYCHOLOGICAL TESTS;

EID: 33845411881     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-954591     Document Type: Article

References (59)

1. Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol 1998; 160: 1627-1637
2. Araga S, Kagimoto H, Funamoto K, Takahashi K. Reduced natural killer cell activity in patients with dementia of the Alzheimer type. Acta Neurol Scand 1991; 84: 259-263
3. 2-induced apoptosis of lymphocytes by calorie restriction during aging. Microsc Res Tech 2002; 59: 282-292
4. Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T. Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord 2005; 11: 493-498
5. Baumann S, Krueger A, Kirchhoff S, Krammer PH. Regulation of T cell apoptosis during the immune response. Curr Mol Med 2002; 2: 257-272
6. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, Canton T, Jedidi I, Gohin M, Wirths O, Bayer TA, Langui D, Duyckaerts C, Tremp G, Pradier L. Time sequence of maturation of dystrophic neuntes associated with Abeta deposits in APP/PS1 transgenic mice. Exp Neurol 2003; 184: 247-263
7. Bullido MJ, Munoz-Fernandez MA, Recuero M, Fresno M, Valdivieso F. Alzheimer's amyloid precursor protein is expressed on the surface of hematopoietic cells upon activation. Biochim Biophys Acta 1996; 1313: 54-62
8. Carson MJ, Sutcliffe JG. Balancing function vs. self defense: the CNS as an active regulator of immune responses. J Neurosci Res 1999; 55: 1-8
9. Colton CA, Brown CM, Cook D, Needham LK, Xu Q, Czapiga M, Saunders AM, Schmechel DE, Rasheed K, Vitek MP. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol Aging 2002; 23: 777-785
10. Czech C, Delaere P, Macq AF, Reibaud M, Dreisler S, Touchet N, Schombert B, Mazadier M, Mercken L, Theisen M, Pradier L, Octave JN, Beyreuther K, Tremp G. Proteolytical processing of mutated human amyloid precursor protein in transgenic mice. Brain Res Mol Brain Res 1997; 47: 108-116
11. Ebstein RP, Nemanov L, Lubarski G, Dano M, Trevis T, Korczyn AD. Changes in expression of lymphocyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer's disease. Brain Res Mol Brain Res 1996; 35: 260-268
12. Eckert A, Cotman CW, Zerfass R, Hennerici M, Muller WE. Enhanced vulnerability to apoptotic cell death in sporadic Alzheimer's disease. Neuroreport 1998; 9: 2443-2446
13. Eckert A, Oster M, Zerfass R, Hennerici M, Muller WE. Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease. Specific differences to vascular dementia. Dement Geriatr Cogn Disord 2001; 12: 98-105
14. Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8+T-cell replicative senescence in human aging. Immunol Rev 2005; 205: 147-157
15. Frey C, Bonert A, Kratzsch T, Rexroth G, Rösch W, Müller-Spahn F, Maurer K, Müller WE, Eckert A. Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer's disease. J Neural Trans 2006, (in press)
16. Fukuyama R, Murakawa Y, Rapoport SI. Induction of gene expression of amyloid precursor protein (APP) in activated human lymphoblastoid cells and lymphocytes. Mol Chem Neuropathol 1994; 23: 93-101
17. Guidi L, Tricerri A, Frasca D, Vangeli M, Errani AR, Bartoloni C. Psychoneuroimmunology and aging. Gerontology 1998; 44: 247-261
18. Gupta S. Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans. Vaccine 2000; 18: 1596-1601
19. Hanisch UK, Neuhaus J, Quirion R, Kettenmann H. Neurotoxicity induced by interleukin-2: involvement of infiltrating immune cells. Synapse 1996; 24: 104-114
20. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001; 36: 118-124
21. Hildeman DA, Mitchell T, Kappler J, Marrack P. T cell apoptosis and reactive oxygen species. J Clin Invest 2003; 111: 575-581
22. + homeostasis in lymphoblasts from patients with late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 1997; 11: 220-227
23. Jakab K, Novak Z, Engelhardt JI, Kemeny L, Kalman J, Vecsei L, Rasko I. UVB irradiation-induced apoptosis increased in lymphocytes of Huntington's disease patients. Neuroreport 2001; 12: 1653-1656
24. Kleine TO, Benes L. Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons. Cytometry A 2006; 69: 147-151
25. Laskowitz DT, Goel S, Bennett ER, Matthew WD. Apolipoprotein E suppresses glial cell secretion of TNF alpha. J Neuroimmunol 1997; 76: 70-74
26. Ledoux S, Bergeron C, Nalbantoglu J, Gauthier S, Cashman NR. Polymerase chain reaction quantification of lymphoid amyloid precursor protein mRNAs in Alzheimer's disease and Down's syndrome. Neurosci Lett 1995; 193: 137-139
27. Ledoux S, Rebai N, Dagenais A, Shaw IT, Nalbantoglu J, Sekaly RP, Cashman NR. Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. J Immunol 1993; 150: 5566-5575
28. Leutner S, Schindowski K, Frölich I, Maurer K, Kratzsch T, Eckert A, Müller WE. Enhanced ROS-Generation in Lymphocytes from Alzheimer's Patients. Pharmacopsychiatry 2005; 38: 312-315
29. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, Muller-Hermelink HK, Steinmann GG. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984; 28: 47-55
30. Lombardi VR, Garcia M, Cacabelow R. APOE-induced microglial activation: an in vitro assay to screen sera from Alzheimer's disease patients and novel therapeutic compounds. Methods Find Exp Clin Pharmacol 1998; 20: 377-386
31. Lombardi VR, Garcia M, Rey L, Cacabelos R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals. J Neuroimmunol 1999; 97: 163-171
32. Masera RG, Prolo P, Sartori ML, Staurenghi A, Griot G, Ravizza L, Dovio A, Chiappelli F, Angeli A. Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease. Psychoneuroendocrinology 2002; 27: 447-461
33. McGavern DB. The role of bystander T cells in CNS pathology and pathogen clearance. Crit Rev Immunol 2005; 25: 289-303
34. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci 2004; 1035: 104-116
35. Monning U, Konig G, Prior R, Mechler H, Schreiter-Gasser U, Masters CL, Beyreuther K. Synthesis and secretion of Alzheimer amyloid beta A4 precursor protein by stimulated human peripheral blood leucocytes. FEBS Lett 1990; 277: 261-266
36. Monsonego A, Zota V, Karni A, Krieger JI, Bar-Or A, Bitan G, Budson AE, Sperling R, Selkoe DJ, Weiner HL. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J Clin Invest 2003; 112: 415-422
37. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139: 271-279
38. Park E, Alberti J, Mehta P, Dalton A, Sersen E, Schuller-Levis G. Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome. Clin Immunol 2000; 95: 62-69
39. Perry VH. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 2004; 18: 407-413
40. Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, Mathews PM, Jucker M. Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 2002; 298: 1379
41. Pirttila T, Mattinen S, Frey H. The decrease of CD8-positive lymphocytes in Alzheimer's disease. J Neurol Sci 1992; 107: 160-165
42. Rogers SL, Coe CL, Karaszewski JW. Immune consequences of stroke and cerebral palsy in adults. J Neuroimmunol 1998; 91: 113-120
43. Rostaing L, Puyoo O, Tkaczuk J, Peres C, Rouzaud A, Cisterne JM, de Preval C, Ohayon E, Durand D, Abbal M. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. Clin Transplant 1999; 13: 400-409
44. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-177
45. Schindowski K, Leutner S, Muller WE, Eckert A. Age-related changes of apoptotic cell death in human lymphocytes. Neurobiol Aging 2000; 21: 661-670
46. Schindowski K, Frohlich L, Maurer K, Muller WE, Eckert A. Age-related impairment of human T lymphocytes' activation: specific differences between CD4(+) and CD8(+) subsets. Mech Ageing Dev 2002; 123: 375-390
47. Schindowski K, Kratzsch T, Peters J, Steiner B, Leutner S, Touchet N, Maurer K, Czech C, Pradier L, Frohlich L, Muller WE, Eckert A. Impact of aging: sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer's disease. Neuromolecular Med 2003; 4: 161-178
48. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 1994; 170: 145-157
49. Schuessel K, Schafer S, Bayer TA, Czech C, Pradier L, Muller-Spahn F, Muller WE, Eckert A. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol Dis 2005; 18: 89-99
50. Shalit F, Sredni B, Brodie C, Kott E, Huberman M. T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin Immunol Immunopathol 1995; 75: 246-250
51. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, Wara DW, Douglas SD, Luzuriaga K, McFarland EJ, Yogev R, Rathore MH, Levy W, Graham BL, Spector SA. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003; 112: 973-980
52. Singh VK. Neuroimmune axis as a basis of therapy in Alzheimer's disease. Prog Drug Res 1990; 34: 383-393
53. Solerte SB, Cravello L, Ferrari E, Fioravanti M. Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease. Ann N Y Acad Sci 2000; 917: 331-340
54. Solerte SB, Fioravanti M, Pascale A, Ferrari E, Govoni S, Battaini F. Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation. Neurobiol Aging 1998; 19: 191-199
55. Suh YH, Chong YH, Kim SH, Choi W, Min K, Jeong SJ, Fraser SP, Djamgoz MB. Molecular physiology, biochemistry, and pharmacology of Alzheimer's amyloid precursor protein (APP). Ann N Y Acad Sci 1996; 786: 169-183
56. Tan J, Town T, Abdullah L, Wu Y, Placzek A, Small B, Kroeger J, Crawford F, Richards D, Mullan M. CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer's disease. J Neuroimmunol 2002; 132: 164-172
57. Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M, Oda T, Tsuchiya K, Kosaka K. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol 2002; 124: 83-92
58. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-1159
59. Zhang X, Fujii H, Kishimoto H, LeRoy E, Surh CD, Sprent J. Aging leads to disturbed homeostasis of memory phenotype CD8(+) cells. J Exp Med 2002; 195: 283-293